Last $49.01 USD
Change Today -0.15 / -0.31%
Volume 205.8K
RDY On Other Exchanges
Symbol
Exchange
New York
Natl India
Frankfurt
Mexico
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for doctor reddy's lab-adr (RDY)

Year over year, Dr. Reddy's Laboratories Ltd. has been able to grow revenues from 115.5B INR to 131.4B INR. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 47.57% to 42.29%. This was a driver that led to a bottom line growth from 16.8B INR to 21.5B INR.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
Restated
INR
Mar 31
2012
Restated
INR
Mar 31
2013
Reclassified
INR
Mar 31
2014
INR
4 Year
Trend
Revenues74,337.096,332.0115,548.0131,350.0
TOTAL REVENUES74,337.096,332.0115,548.0131,350.0
Cost of Goods Sold34,074.043,027.054,969.055,549.0
GROSS PROFIT40,263.053,305.060,579.075,801.0
Selling General & Admin Expenses, Total23,689.028,867.033,584.039,280.0
R&D Expenses5,060.05,911.07,782.012,402.0
Other Operating Expenses-851.0-784.0-1,056.0-948.0
OTHER OPERATING EXPENSES, TOTAL27,898.033,994.040,310.050,734.0
OPERATING INCOME12,365.019,311.020,269.025,067.0
Interest Expense-232.0-1,067.0-1,018.0-1,274.0
Interest and Investment Income105.0538.01,113.01,302.0
NET INTEREST EXPENSE-127.0-529.095.028.0
Income (Loss) on Equity Investments3.054.0104.0174.0
Currency Exchange Gains (Loss)-57.0689.0365.0372.0
Other Non-Operating Income (Expenses)0.0------
EBT, EXCLUDING UNUSUAL ITEMS12,184.019,525.020,833.025,641.0
Impairment of Goodwill73.0---181.0--
Gain (Loss) on Sale of Investments68.0------
Gain (Loss) on Sale of Assets271.0-9.0143.053.0
Other Unusual Items, Total-153.0-1,050.0881.0912.0
Legal Settlements-80.0-10.01,388.0415.0
Other Unusual Items-73.0------
EBT, INCLUDING UNUSUAL ITEMS12,443.018,466.021,676.026,606.0
Income Tax Expense1,403.04,204.04,900.05,094.0
Minority Interest in Earnings----1.03.0
Earnings from Continuing Operations11,040.014,262.016,776.021,512.0
NET INCOME11,040.014,262.016,777.021,515.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS11,040.014,262.016,777.021,515.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS11,040.014,262.016,777.021,515.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDY:US $49.01 USD -0.15

RDY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 529.15 INR +14.95
Croda International PLC 2,214 GBp +32.00
Endo International PLC $63.71 USD -0.31
Lupin Ltd 1,290 INR +4.45
Symrise AG €40.30 EUR -0.30
View Industry Companies
 

Industry Analysis

RDY

Industry Average

Valuation RDY Industry Range
Price/Earnings 21.5x
Price/Sales 3.6x
Price/Book 5.2x
Price/Cash Flow 21.5x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DOCTOR REDDY'S LAB-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.